Compare CFG & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CFG | IQV |
|---|---|---|
| Founded | 1828 | 1982 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 36.4B |
| IPO Year | 2014 | 2013 |
| Metric | CFG | IQV |
|---|---|---|
| Price | $59.80 | $224.26 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 18 | 15 |
| Target Price | $57.28 | ★ $236.93 |
| AVG Volume (30 Days) | ★ 5.4M | 1.5M |
| Earning Date | 01-16-2026 | 02-05-2026 |
| Dividend Yield | ★ 2.84% | N/A |
| EPS Growth | ★ 41.06 | N/A |
| EPS | 3.57 | ★ 7.30 |
| Revenue | $7,443,000,000.00 | ★ $15,904,000,000.00 |
| Revenue This Year | $17.12 | $6.14 |
| Revenue Next Year | $8.13 | $5.35 |
| P/E Ratio | ★ $16.58 | $30.22 |
| Revenue Growth | ★ 4.61 | 3.85 |
| 52 Week Low | $32.60 | $134.65 |
| 52 Week High | $59.33 | $234.30 |
| Indicator | CFG | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 76.72 | 54.08 |
| Support Level | $58.09 | $219.91 |
| Resistance Level | $59.22 | $225.80 |
| Average True Range (ATR) | 1.13 | 5.21 |
| MACD | 0.19 | -0.79 |
| Stochastic Oscillator | 98.19 | 61.70 |
Citizens Financial Group Inc is a bank holding company headquartered in Providence, Rhode Island. Through the bank, it offers various retail and commercial banking products and services to individuals, small businesses, middle-market companies, large corporations, and institutions. The company's reportable segments are; Commercial Banking, Consumer Banking, Non-Core, and Others. A majority of its revenue is generated from the Consumer Banking segment, which serves consumer customers and small businesses, offering traditional banking products and services including deposits, mortgage and home equity lending, credit cards, small business loans, education loans, point-of-sale finance loans, and wealth management and investment services.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.